Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Neurexin 1 ELISA Kit (AC2433)
Cat.#: ASET-1022
Specifications
Description Human Neurexin 1 ELISA Kit allows for the in vitro quantitative determination of human Neurexin 1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1362 Mouse Urocortin ELISA Kit (AC2773) Quantitative inquiry ASET-1189 Rat Renalase ELISA Kit (AC2600) Quantitative inquiry ASET-1229 Rat Calretinin ELISA Kit (AC2640) Quantitative inquiry ASET-1173 Mouse Wnt8b ELISA Kit (AC2584) Quantitative inquiry ASET-2413 Mouse Has3 ELISA Kit (AC3824) Quantitative inquiry ASET-1329 Human MC1-R ELISA Kit (AC2740) Quantitative inquiry ASET-2046 Human Activin B ELISA Kit (AC3457) Quantitative inquiry ASET-2430 Human KCNK15 ELISA Kit (AC3841) Quantitative inquiry ASET-1482 Human Ki67 ELISA Kit (AC2893) Quantitative inquiry ASET-1670 Human Histidine Decarboxylase ELISA Kit (AC3081) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket